Moderna COVID-19 Vaccine Summary | Vaccines & Immunizations …
Aug 28, 2024 · Moderna COVID-19 Vaccine 2024-2025 Formula is indicated for people 6 months through 11 years of age. Moderna SPIKEVAX ® is indicated for people 12 years and older
Moderna COVID-19 Vaccine At-A-Glance Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2024–25 Moderna COVID-19 vaccine products. Distributed in: Ages: 6 months through 11 years Manufacturer-filled syringe Ages: 12 years and older Manufacturer-filled syringe Storage and Handling
Find vaccines by Moderna near you
1-866-MODERNA (1-866-663-3762) 8:00 AM - 8:00 PM ET Monday - Friday (closed holidays)
Moderna COVID-19 vaccine - Wikipedia
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced …
Moderna COVID-19 Vaccine | FDA
Nov 4, 2024 · The Moderna COVID-19 Vaccine (2024-2025 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.
Comparing the differences between COVID-19 vaccines
Sep 16, 2024 · Moderna COVID-19 vaccine 2024-2025 formula is authorized for people ages 6 months through 11 years. Spikevax is approved for people age 12 and older. The vaccines that help protect against COVID-19 are safe and effective based …
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single)...
Moderna COVID-19 vaccine - Drugs.com
Aug 27, 2024 · The Moderna COVID-19 vaccine 2024-2025 Formula is an mRNA COVID-19 vaccine that may help your child develop immunity to SARS-CoV-2, the virus that causes COVID-19. The number of doses depends on age, vaccination status, and immune system status.
Moderna COVID-19 Vaccine is a vaccine for use in individuals 6 months through 11 years of age to prevent COVID-19. The FDA has authorized the emergency use of Moderna COVID-19
Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine - Moderna
I am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccine for this fall for individuals 12 years of age and older. The updated vaccine composition targets the KP.2 variant, based on guidance from the U.S. FDA.